Immutep Statistics
NASDAQ: IMMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.06-0.28 (-6.45%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Immutep by the numbers
Immutep has a market capitalization of $29.9 million based on 7.37M shares outstanding. With trailing EPS of $-6.82, Immutep is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 40.6% below its 50-day average and 81.5% below its 200-day average.
Average daily trading volume is 14.78K shares, or about $59,986 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IMMP valuation vs. peer median
| Metric | IMMP | Peer median | Difference |
|---|---|---|---|
| Market cap | $29.92M | $29.59M | +1% |
| Avg. volume | 14.78K | 346.98K | -96% |
Peer median across 8 companies: MIRA, NXTC, RNAZ, GRDX, IGC, CNTX, MCRB, RMTI.
Valuation
- Market cap
- $29.92M
- EPS (TTM)
- $-6.82
- Shares outstanding
- 7.37M
Price and trading
- Previous close
- 4.34
- Open
- 4.31
- Day range
- 4.04 – 4.31
- 52-week range
- 4.04 – 70.60
- 52-week change
- +95.19%
- Beta
- —
- Volume
- 9.15K
- Average volume
- 14.78K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Sep 3, 2026
Additional statistics
- Market Cap
- 29.92M
- Forward Pe
- -0.78
- Eps
- -6.82
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 70.60
- Week52 Low
- 4.04
- Avg Volume
- 14,775.00
- Shares Outstanding
- 7.37M
- Ma50
- 6.83
- Ma200
- 21.95
- Earnings Date
- Sep 3, 2026
- Pct From52w High
- -94.25%
- Pct From52w Low
- 0.50%